Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Yoshihiko Kishibe"'
Autor:
Tomoko Okina, Tatsuya Higashi, Yasuhiro Nagahama, Naoya Oishi, Masaaki Takahashi, Chio Okuyama, Norio Suzuki, Hiroshi Yamauchi, Hideo Saji, Shinya Kagawa, Ryuichi Nishii, Hiroyuki Kimura, Hiroyuki Watanabe, Koichi Ishizu, Masahiro Ono, Hiroshi Hasegawa, Yoshihiko Kishibe
Publikováno v:
Annals of Nuclear Medicine. 32:256-263
Recently, a benzofuran derivative for the imaging of β-amyloid plaques, 5-(5-(2-(2-(2-18F-fluoroethoxy)ethoxy)ethoxy)benzofuran-2-yl)- N-methylpyridin-2-amine (18F-FPYBF-2) has been validated as a tracer for amyloid imaging and it was found that 18F
Autor:
Ryuichi Nishii, Toshinori Hirai, Tatsuya Fujii, Tomohiro Kumada, Tatsuya Higashi, Shinya Kagawa, Yoshihiko Kishibe, Masaaki Takahashi, Hiroshi Yamauchi, Chio Okuyama, Shigeki Nagamachi
Publikováno v:
Imaging in Medicine. 10(1):9-16
Objectives :- A ketogenic diet (KD) is a strict dietary protocol that incorporates high-fat, low-protein, and low-carbohydrate foods. Increasing the levels of ketones became an eventual and effective treatment strategy for medically refractory epilep
Autor:
Ryuichi Nishii, Norio Suzuki, Hiroshi Yamauchi, Tomoko Okina, Yasuhiro Nagahama, Koichi Ishizu, Hiroshi Hasegawa, Masahiro Ono, Hiroyuki Watanabe, Yoshihiko Kishibe, Hiroyuki Kimura, Naoya Oishi, Masaaki Takahashi, Tatsuya Higashi, Hideo Saji, Shinya Kagawa
Publikováno v:
Annals of Nuclear Medicine
Objective Recently, we developed a benzofuran derivative for the imaging of β-amyloid plaques, 5-(5-(2-(2-(2-18F-fluoroethoxy)ethoxy)ethoxy)benzofuran-2-yl)-N-methylpyridin-2-amine (18F-FPYBF-2) (Ono et al., J Med Chem 54:2971–9, 2011). The aim of
Publikováno v:
Stroke. 47:1534-1541
Background and Purpose— Cross-sectional studies suggest that chronic hemodynamic impairment may cause selective cortical neuronal damage in patients with atherosclerotic internal carotid artery or middle cerebral artery occlusive disease. The purpo
Autor:
Shinya Kagawa, Masato Hojo, Tatsuya Higashi, Shigeki Nagamachi, Masahiro Sawada, Yoshiki Arakawa, Toshinori Hirai, Ryuichi Nishii, Hiroshi Yamauchi, Chio Okuyama, Masaaki Takahashi, Keiichi Kawai, Shigeki Yamada, Maya Arimoto, Toshihiro Munemitsu, Yoshihiko Kishibe, Masaaki Saiki, Susumu Miyamoto, Masato Kobayashi
Publikováno v:
Contrast Media & Molecular Imaging, Vol 2018 (2018)
Contrast Media & Molecular Imaging
Contrast Media & Molecular Imaging
Introductions. [N-methyl-C-11]α-Methylaminoisobutyric acid (MeAIB) is an artificial amino acid radiotracer used for PET study, which is metabolically stable in vivo. In addition, MeAIB is transported by system A neutral amino acid transport, which i
Autor:
Shinya Kagawa, Hirotaka Onoe, Kazuhiro Takahashi, Hiroshi Yamauchi, Yoshihiko Kishibe, Tatsuya Higashi, Masaaki Takahashi, Hiroshi Mizuma, Ryuichi Nishii
Publikováno v:
Stroke. 46:2669-2672
Background and Purpose— [18F]-fluoroacetate ( 18 F-FACE) can be used for evaluating glial cell metabolism. Experimental studies have shown an increase in 18 F-FACE uptake in rodent models of cerebral ischemia. The aim of this study was to determine
Publikováno v:
AJNR Am J Neuroradiol
BACKGROUND AND PURPOSE: Misery perfusion may cause selective neuronal damage in atherosclerotic ICA or MCA disease. Bypass surgery can improve misery perfusion and may prevent neuronal damage. On the other hand, surgery conveys a risk for neuronal da
Publikováno v:
Journal of Neurology, Neurosurgery, and Psychiatry
Objective Blood pressure (BP) lowering may increase stroke risk in patients with symptomatic major cerebral artery disease and impaired perfusion. To investigate the relationships among BP, impaired perfusion and stroke risk. Methods We retrospective
Publikováno v:
AJNR Am J Neuroradiol
BACKGROUND AND PURPOSE: In asymptomatic or remote symptomatic LAICOD, the risk of ischemic events is low in general, but there may be a subgroup of higher risk patients who require aggressive medical management. The purpose of this study was to deter
Autor:
Ryuichi Nishii, Maya Arimoto, Shinya Kagawa, Satoshi Ishitoya, Tatsuya Higashi, Kaori Togashi, Yoshihiko Kishibe, Hiroshi Yamauchi, Yuji Nakamoto, Masaaki Takahashi, Hiroyuki Oonishi
Publikováno v:
Annals of nuclear medicine. 30(8)
α-N-methyl-(11)C-methylaminoisobutyric acid ((11)C-MeAIB) is a selective substrate of system A amino acid transport, and known to accumulate in malignant lesions. The aim of this study was to evaluate the utility of MeAIB PET for the assessment of p